nodes	percent_of_prediction	percent_of_DWPC	metapath
Flupentixol—ABCB1—Lisinopril—dilated cardiomyopathy	0.39	0.532	CbGbCtD
Flupentixol—ABCB1—Spironolactone—dilated cardiomyopathy	0.344	0.468	CbGbCtD
Flupentixol—Trifluoperazine—TNNC1—dilated cardiomyopathy	0.0196	1	CrCbGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000542	0.0022	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000534	0.00216	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000531	0.00215	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00053	0.00215	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000525	0.00213	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000524	0.00212	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.000522	0.00212	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000517	0.00209	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000515	0.00209	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000514	0.00208	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000512	0.00208	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000506	0.00205	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000504	0.00204	CbGpPWpGaD
Flupentixol—DRD2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000497	0.00201	CbGpPWpGaD
Flupentixol—HTR2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000489	0.00198	CbGpPWpGaD
Flupentixol—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000486	0.00197	CbGpPWpGaD
Flupentixol—DRD2—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00048	0.00195	CbGpPWpGaD
Flupentixol—ADRA1A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000479	0.00194	CbGpPWpGaD
Flupentixol—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.00047	0.0019	CbGpPWpGaD
Flupentixol—HTR2A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000469	0.0019	CbGpPWpGaD
Flupentixol—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000466	0.00189	CbGpPWpGaD
Flupentixol—ADRA1A—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.000459	0.00186	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000452	0.00183	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000449	0.00182	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000444	0.0018	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000444	0.0018	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000441	0.00179	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000439	0.00178	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000437	0.00177	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000437	0.00177	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000435	0.00176	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000435	0.00176	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000432	0.00175	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000429	0.00174	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000428	0.00173	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000428	0.00173	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000426	0.00172	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000419	0.0017	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000419	0.0017	CbGpPWpGaD
Flupentixol—DRD1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000418	0.00169	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000417	0.00169	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000416	0.00169	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000413	0.00167	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.000411	0.00166	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00041	0.00166	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000406	0.00165	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000405	0.00164	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000404	0.00164	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.0004	0.00162	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000398	0.00161	CbGpPWpGaD
Flupentixol—DRD2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000397	0.00161	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000394	0.0016	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000394	0.0016	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000394	0.00159	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000391	0.00159	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.000388	0.00157	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000385	0.00156	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000366	0.00148	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000342	0.00138	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000336	0.00136	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000334	0.00135	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000332	0.00135	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000332	0.00135	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000329	0.00133	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000324	0.00131	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000321	0.0013	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000319	0.00129	CbGpPWpGaD
Flupentixol—DRD1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000318	0.00129	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000317	0.00128	CbGpPWpGaD
Flupentixol—DRD2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000316	0.00128	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000312	0.00126	CbGpPWpGaD
Flupentixol—HTR2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000311	0.00126	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.00031	0.00125	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000309	0.00125	CbGpPWpGaD
Flupentixol—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000309	0.00125	CbGpPWpGaD
Flupentixol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000304	0.00123	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000304	0.00123	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000302	0.00122	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000302	0.00122	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000299	0.00121	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000291	0.00118	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00029	0.00117	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.000285	0.00115	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000281	0.00114	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000272	0.0011	CbGpPWpGaD
Flupentixol—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000266	0.00108	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000266	0.00108	CbGpPWpGaD
Flupentixol—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.000266	0.00108	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000256	0.00104	CbGpPWpGaD
Flupentixol—DDC—Metabolism—GPX1—dilated cardiomyopathy	0.000252	0.00102	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000251	0.00102	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000251	0.00102	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.00025	0.00101	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000247	0.001	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000247	0.001	CbGpPWpGaD
Flupentixol—HTR2A—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.000246	0.000995	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000246	0.000995	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000246	0.000995	CbGpPWpGaD
Flupentixol—DDC—Metabolism—CD36—dilated cardiomyopathy	0.000246	0.000995	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000243	0.000983	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000242	0.00098	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000242	0.00098	CbGpPWpGaD
Flupentixol—DRD2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00024	0.000974	CbGpPWpGaD
Flupentixol—HTR2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000237	0.000958	CbGpPWpGaD
Flupentixol—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000235	0.000953	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000233	0.000945	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000232	0.000941	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000232	0.000938	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00023	0.00093	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000228	0.000925	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000228	0.000923	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000228	0.000923	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.000226	0.000917	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000226	0.000916	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000225	0.000911	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000224	0.000909	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000224	0.000909	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000223	0.000904	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000223	0.000904	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000222	0.000901	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000221	0.000896	CbGpPWpGaD
Flupentixol—DDC—Metabolism—AGT—dilated cardiomyopathy	0.000221	0.000896	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00022	0.000892	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00022	0.00089	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00022	0.00089	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000218	0.000882	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000212	0.000858	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000209	0.000845	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000207	0.00084	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000205	0.000831	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000204	0.000827	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000202	0.000818	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000201	0.000815	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000201	0.000814	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000201	0.000814	CbGpPWpGaD
Flupentixol—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.0002	0.000809	CbGpPWpGaD
Flupentixol—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000199	0.000804	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000198	0.000801	CbGpPWpGaD
Flupentixol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.000195	0.000792	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000193	0.000782	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00019	0.000769	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000189	0.000765	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000188	0.000763	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000186	0.000753	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000183	0.000742	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00018	0.00073	CbGpPWpGaD
Flupentixol—DRD1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00018	0.000729	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000179	0.000726	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000178	0.000723	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000178	0.000723	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000176	0.000715	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000175	0.00071	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000172	0.000699	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000172	0.000695	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000171	0.000693	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000169	0.000684	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000166	0.000674	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000166	0.000672	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000164	0.000663	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000163	0.000662	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000163	0.000659	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000161	0.000651	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00016	0.000649	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000152	0.000614	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000149	0.000605	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000148	0.000601	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000146	0.000592	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000142	0.000576	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.00014	0.000567	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000139	0.000564	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	0.000138	0.000559	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000137	0.000556	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000137	0.000555	CbGpPWpGaD
Flupentixol—DRD2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000136	0.00055	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000135	0.000546	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000135	0.000546	CbGpPWpGaD
Flupentixol—HTR2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000134	0.000541	CbGpPWpGaD
Flupentixol—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000133	0.000539	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000133	0.000537	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000133	0.000537	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000132	0.000534	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000132	0.000534	CbGpPWpGaD
Flupentixol—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	0.000131	0.000533	CbGpPWpGaD
Flupentixol—ADRA1A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000131	0.00053	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.00013	0.000527	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.00013	0.000526	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.00013	0.000526	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000129	0.000523	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000127	0.000515	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000126	0.000512	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000125	0.000507	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000124	0.000504	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000123	0.0005	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000123	0.000499	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000123	0.000496	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000121	0.000492	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000121	0.000491	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000121	0.000489	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000121	0.000489	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000119	0.000483	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000119	0.000481	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000119	0.000481	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000117	0.000473	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000113	0.000459	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000112	0.000453	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000104	0.000419	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000102	0.000413	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000101	0.000411	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000101	0.000409	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AGTR1—dilated cardiomyopathy	9.98e-05	0.000404	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.82e-05	0.000398	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.67e-05	0.000392	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—AGT—dilated cardiomyopathy	9.65e-05	0.000391	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.61e-05	0.000389	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—ADRB2—dilated cardiomyopathy	9.46e-05	0.000383	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.56e-05	0.000347	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.44e-05	0.000342	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.42e-05	0.000341	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.38e-05	0.000339	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.31e-05	0.000336	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.26e-05	0.000335	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—RAF1—dilated cardiomyopathy	8.25e-05	0.000334	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	8.13e-05	0.000329	CbGpPWpGaD
Flupentixol—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	7.99e-05	0.000324	CbGpPWpGaD
Flupentixol—DRD1—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.78e-05	0.000315	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RAC1—dilated cardiomyopathy	7.63e-05	0.000309	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.5e-05	0.000304	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	7.46e-05	0.000302	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RAC1—dilated cardiomyopathy	7.35e-05	0.000298	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—AGT—dilated cardiomyopathy	7.29e-05	0.000295	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—AGT—dilated cardiomyopathy	7.17e-05	0.00029	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	7.13e-05	0.000289	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—AGT—dilated cardiomyopathy	7.02e-05	0.000284	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.7e-05	0.000271	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	6.15e-05	0.000249	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—CD36—dilated cardiomyopathy	5.99e-05	0.000243	CbGpPWpGaD
Flupentixol—DRD2—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.87e-05	0.000238	CbGpPWpGaD
Flupentixol—HTR2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.78e-05	0.000234	CbGpPWpGaD
Flupentixol—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.75e-05	0.000233	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling by GPCR—EGFR—dilated cardiomyopathy	5.66e-05	0.000229	CbGpPWpGaD
Flupentixol—ABCB1—Metabolism—AGT—dilated cardiomyopathy	5.39e-05	0.000219	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—RAF1—dilated cardiomyopathy	5.06e-05	0.000205	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.98e-05	0.000202	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	4.95e-05	0.0002	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—RAF1—dilated cardiomyopathy	4.87e-05	0.000197	CbGpPWpGaD
Flupentixol—DRD1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.59e-05	0.000186	CbGpPWpGaD
Flupentixol—DRD2—Signaling Pathways—EGFR—dilated cardiomyopathy	3.47e-05	0.00014	CbGpPWpGaD
Flupentixol—HTR2A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.41e-05	0.000138	CbGpPWpGaD
Flupentixol—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	3.39e-05	0.000137	CbGpPWpGaD
Flupentixol—ADRA1A—Signaling Pathways—EGFR—dilated cardiomyopathy	3.34e-05	0.000135	CbGpPWpGaD
